HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis

Molecular and Cellular Neurosciences

Volumn 15, Issue 6, 2000, Pages 495-509

  Pavelko, Kevin D ^a   Drescher, Kristen M ^a   McGavern, Dorian B ^a   David, Chella S ^a   Rodriguez, Moses ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DQ ANTIGEN;

ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BRAIN; CELLULAR IMMUNITY; CONTROLLED STUDY; DEMYELINATION; DNA POLYMORPHISM; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOMODULATION; MOUSE; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PATHOPHYSIOLOGY; PERSISTENT VIRUS INFECTION; PRIORITY JOURNAL; SPINAL CORD; TRANSGENE; VIRUS REPLICATION;

ANIMALIA; MURINAE; THEILER'S ENCEPHALOMYELITIS VIRUS;

EID: 0033945769     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1006/mcne.2000.0843     Document Type: Article

References (43)

1. Aldrich M. S. Diagnostic aspects of narcolepsy. Neurology. 50:1998;S2-S7.
2. Alpsoy E., Yilmaz E., Coskun M., Savas A., Yegin O. HLA antigens and linkage disequilibrium patterns in Turkish Behcet's patients. J. Dermatol. 25:1998;158-162.
3. Aubert C., Chamorro M., Brahic M. Identification of Theiler's virus infected cells in the central nervous system of the mouse during demyelinating disease. Microb. Pathog. 3:1987;319-326.
4. Black C., Briggs D., Welsh K. The immunogenetic background of scleroderma - An overview. Clin. Exp. Dermatol. 17:1992;73-78.
5. Cash E., Bandeira A., Chirinian S., Brahic M. Characterization of B lymphocytes present in the demyelinating lesion induced by Theiler's virus. J. Immunol. 143:1989;984-988.
6. Clatch R. J., Melvold R. W., Miller S. D., Lipton H. L. Theiler's murine encephalomyelitis virus (TMEV)-induced demyelinating disease in mice is influenced by the H-2D region: Correlation with TMEV-specific delayed-type hypersensitivity. J. Immunol. 135:1985;1408-1414.
7. Clatch R. J., Miller S. D., Metzner R., Dal Canto M. C., Lipton H. L. Monocytes/macrophages isolated from the mouse central nervous system contain infectious Theiler's murine encephalomyelitis virus (TMEV). Virology. 176:1990;244-254.
8. Dal Canto M. C., Lipton H. L. Ultrastructural immunohistochemical localization of virus in acute and chronic demyelinating Theiler's virus infection. Am. J. Pathol. 106:1982;20-29.
9. Das P., Drescher K. M., Geluk A., Bradley D. S., Rodriguez M., David C. S. Complementation between specific HLA-DR and HLA-DQ genes in transgenic mice determines susceptibility to experimental autoimmune encephalomyelitis. Hum. Immunol. 1999.
10. Drescher K. M., Murray P. D., David C. S., Pease L. R., Rodriguez M. CNS cell populations are protected from virus-induced pathology by distinct arms of the immune system. Brain Pathol. 9:1999;21-31.
11. Drescher K. M., Nguyen L. T., Taneja V., Coenen M. J., Leibowitz J. L., Strauss G., Hammerling G. J., David C. S., Rodriguez M. Expression of the human histocompatibility leukocyte antigen DR3 transgene reduces the severity of demyelination in a murine model of multiple sclerosis. J. Clin. Invest. 101:1998;1765-1774.
12. Duquette P., Decary F., Pleines J., Boivin D., Lamareoux G., Cosgrove J. B., Lapierre Y. Clinical subgroups of multiple sclerosis in relation to the HLA: DR alleles as possible markers of disease progression. Can. J. Neurosci. 12:1985;106-110.
13. Halperin J. J., Volkman D. J., Wu P. Central nervous system abnormalities in Lyme neuroborreliosis. Neurology. 41:1991;1571-1582.
14. Isreal E. J., Wilsker D. F., Hayes K. C., Schoenfeld D., Simister N. E. Increased clearance of IgG in mice that lack beta 2-microglobulin: Possible protective role of FcRn. Immunology. 89:1996;573-578.
15. Kadotani H., Faraco J., Mignot E. Genetic studies in the sleep disorder narcolepsy. Genome Res. 8:1998;427-434.
16. Kott E., Livni E., Zamir R., Kuritzky A. Cell-mediated immunity to polio and HLA antigens in amyotropic lateral sclerosis. Neurology. 29:1979;1040-1044.
17. Lipton H. L. Theiler's virus infection in mice: An unusual biphasic disease process leading to demyelination. Infect. Immun. 11:1975;1147-1155.
18. Lipton H. L., Twaddle G., Jelachich M. L. The predominant virus antigen burden is present in macrophages in Theiler's murine encephalomyelitis virus-induced demyelinating disease. J. Virol. 69:1995;2525-2533.
19. McGavern D. B., Zoecklein L., Drescher K. M., Rodriguez M. Quantitive assessment of neurologic deficits in a chronic progressive murine model of CNS demyelination. Exp. Neurol. 158:1999;171-181.
20. Murray P. D., McGavern D. B., Lin X., Njenga M. K., Leibowitz J., Pease L. R., Rodriguez M. Perforin-dependent neurologic injury in a viral model of multiple sclerosis. J. Neurosci. 18:1998;7306-7314.
21. Njenga M. K., Pavelko K. D., Baisch J., Lin X., David C., Leibowitz J., Rodriguez M. Theiler's virus persistence and demyelination in major histocompatibility complex class II-deficient mice. J. Virol. 70:1996;1729-1737.
22. Oldstone M. B. A. Molecular mimicry and immune-mediated diseases. FASEB J. 12:1998;1255-1265.
23. Olerup O., Hillert J., Fredrickson S., Olsson T., Kan-Hansen S., Moller E., Carlsson B., Wallin J. Primary chronic progressive and relapsing/remitting multiple sclerosis: Two immunologically distinct disease entities. Proc. Natl. Acad. Sci. USA. 86:1989;7113-7117.
24. Patick A. K., Thiemann R. L., O'Brien P. C., Rodriguez M. Persistence of Theiler's virus infection following promotion of central nervous system remyelination. J. Neuropathol. Exp. Neurol. 50:1991;523-537.
25. Paya C. V., Leibson P. J., Patick A. K., Rodriguez M. Inhibition of Theiler's virus-induced demyelination in vivo by tumor necrosis factor alpha. Int. Immunol. 2:1990;909-913.
26. Paya C. V., Patick A., Leibson P. J., Rodriguez M. Role of natural killer cells as immune effectors in encephalitis and demyelination induced by Theiler's virus. J. Immunol. 143:1989;95-102.
27. Pierce M. L., Rodriguez M. Erichrome stain for myelin on osmicated tissue embedded in glycol methacrylate plastic. J. Histotech. 12:1989;35.
28. Prineas J. W., Wright R. G. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab. Invest. 38:1978;409-421.
29. Raju R., Munn S. R., Majoribanks C., David C. S. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7. Transplant. Proc. 30:1998;561.
30. Rivera-Quinones C., McGavern D., Schmelzer J. D., Hunter S. F., Low P. A., Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat. Med. 4:1998;187-193.
31. Rodriguez M., David C. S. Demyelination induced by Theiler's virus: Influence of the H-2 haplotype. J. Immunol. 135:1985;2145-2148.
32. b mice deficient in β 2-microglobulin. J. Immunol. 151:1993;266-276.
33. Rodriguez M., Leibowitz J., David C. S. Susceptibility to Theiler's virus-induced demyelination: Mapping of the gene within the H-2D region. J. Exp. Med. 163:1986a;620-631.
34. Rodriguez M., Lafuse W., Leibowitz J., David C. S. Partial suppression of Theiler's virus-induced demyelination in vivo by administration of monoclonal antibodies to immune response gene products (Ia antigens). Neurology. 36:1986b;964-970.
35. Rodriguez M., Leibowitz J. L., Lampert P. W. Persistent infection of oligodendrocytes in Theiler's virus-induced encephalomyelitis. Ann. Neurol. 13:1983;426-433.
36. Rodriguez M., Lucchinetti C. F., Clark R. J., Yaksh T. L., Markowitz H., Lennon V. A. Immunoglobulins and complement in demyelination induced in mice by Theiler's virus. J. Immunol. 140:1988;800-806.
37. Rodriguez M., Pavelko K. D., Njenga M. K., Logan W. C., Wettstein P. J. The balance between persistent virus infection and immune cells determines demyelination. J. Immunol. 157:1996;5699-5709.
38. Rodriguez M., Pierce M. L., Howie E. A. Immune response gene products (Ia antigens) on glial and endothelial cells in virus-induced demyelination. J. Immunol. 138:1987;3438-3442.
39. Rodriguez M., Sriram S. Successful therapy of TMEV-induced demyelination (DA strain) with monoclonal anti lyt2.2 antibody. J. Immunol. 140:1988;2950-2955.
40. Tola M. R., Caniatti L. M., Casetta I., Granieri E., Conighi C., Quatrale R., Monetti V. C., Paolino E., Govoni V., Pascarella R. Immunogenetic heterogeneity and associated autoimmune disorders in myasthenia gravis: A population-based survey in the province of Ferrara, northern Italy. Acta Neurol. (Scand.). 90:1994;318-323.
41. Tuohy V. K., Yu M., Yin L., Kawczak J. A., Johnson J. M., Mathisen P. M., Weistock-Guttman B., Kinkel R. P. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Immunol. Rev. 164:1998;93-100.
42. Weinshenker B. G., Santrach P., Bissonet A. S., McDonnell S. K., Schaid D., Moore S. B., Rodriguez M. Major histocompatibility complex class II alleles and the course and outcome of MS: A population-based study. Neurology. 51:1998;742-747.
43. Zanelli E., Krco C. J., Baisch J., Cheng S., David C. S. Could HLA-DRB1 be a protective locus in rheumatoid arthritis? Immunol. Today. 16:1996;274-276.